Received: 6 March 2023
Accepted: 16 July 2023
First Online: 1 September 2023
Change Date: 25 September 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s40662-023-00360-3
: All procedures were performed in accordance with relevant guidelines. The ethics committee of Canton Zurich (Zurich Kantonale Ethikkommission, BASEC-Nr. Req-2021-01121) waived the need for written informed consent and ethical approval for the study.
: Not applicable.
: NH is CEO of EMAGine AG, a company producing a CXL device. FH holds a patent on a UV light source (PCT/CH 2012/000090) and is CSO of EMAGine AG. FH is an editorial board member of Eye and Vision. The other authors have no proprietary or commercial interest in any of the materials discussed in this article.